Illumina Inc (ILMN.OQ)

ILMN.OQ on NASDAQ Stock Exchange Global Select Market

27 Nov 2015
Change (% chg)

$5.10 (+2.83%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ILMN.OQ


Illumina, Inc. is engaged in production development of sequencing-and array-based solutions for genetic analysis. The Company offers integrated systems, consumables and analysis tools for genetic analysis. It also manufactures sequencing and array platforms, reagent kits and scanning equipment. Its customers include genomic... (more)


Beta: 0.70
Market Cap(Mil.): $27,165.98
Shares Outstanding(Mil.): 146.40
Dividend: --
Yield (%): --


  ILMN.OQ Industry Sector
P/E (TTM): 54.16 231.68 34.31
EPS (TTM): 3.43 -- --
ROI: 18.33 3.09 14.77
ROE: 31.79 3.60 15.97
Search Stocks

Circuit revives challenge to Illumina Down Syndrome test patent

A federal appeals court has revived a petition by Roche AG unit Ariosa Diagnostics seeking to invalidate a rival's patent on a noninvasive prenatal test for Down Syndrome.

16 Nov 2015

Biotechs extend selloff as pricing concerns intensify

NEW YORK U.S. biotech shares extended their recent downward spiral on Tuesday as concerns about drug pricing continued to plague the sector while disappointing news from Illumina and other companies added to selling pressure.

06 Oct 2015

BRIEF-Inno-Gene signs investment deal with International Technology Ventures

* Signs investment deal with US-based International Technology Ventures, LLC (ITV)

09 Sep 2015

Illumina partners with private equity firm on gene JV: sources

Gene-sequencing giant Illumina Inc, private equity firm Warburg Pincus LLC and venture capital firm Sutter Hill Ventures have agreed to invest $100 million to seed a new consumer-facing human genome platform called Helix, according to people familiar with the deal.

18 Aug 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
Provider : ValuEngine, Inc.
Provider : Pechala's Reports
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks